Stock PHAS.Q PHASEBIO PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News PhaseBio Pharmaceuticals, Inc.

Equities

PHAS.Q

US7172241090

End-of-day quote OTC Markets
Other stock markets
 06:00:00 2024-04-15 pm EDT 		5-day change 1st Jan Change
0.000001 USD 0.00% Intraday chart for PhaseBio Pharmaceuticals, Inc. 0.00% 0.00%
Apr. 19 First Amended Combined Liquidation Plan and Disclousre Statement Filed by PhaseBio Pharmaceuticals, Inc. CI
Feb. 07 Fifth Motion for Exclusivity Period Extension Approved For PhaseBio Pharmaceuticals, Inc. CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
First Amended Combined Liquidation Plan and Disclousre Statement Filed by PhaseBio Pharmaceuticals, Inc.
CI
Fifth Motion for Exclusivity Period Extension Approved For PhaseBio Pharmaceuticals, Inc.
CI
Fourth Motion for Exclusivity Period Extension Approved For PhaseBio Pharmaceuticals, Inc.
CI
PhaseBio Pharmaceuticals, Inc. Announces Resignation of Caroline Loewy as Member of the Board of Directors
CI
Third Motion for Exclusivity Period Extension Approved For PhaseBio Pharmaceuticals, Inc.
CI
Modified Combined Disclosure Statement Approved on Interim Basis for PhaseBio Pharmaceuticals, Inc.
CI
Second Motion for Exclusivity Period Extension Approved For PhaseBio Pharmaceuticals, Inc.
CI
Combined Liquidation Plan and Disclousre Statement Filed by PhaseBio Pharmaceuticals, Inc.
CI
North American Morning Briefing : Sentiment -2-
DJ
North American Morning Briefing : Traders Await -2-
DJ
North American Morning Briefing : Stock Futures -3-
DJ
First Motion for Exclusivity Period Extension Approved For PhaseBio Pharmaceuticals, Inc.
CI
First Motion for Exclusivity Period Extension Filed by PhaseBio Pharmaceuticals, Inc.
CI
Motion for Asset Sale Approved for PhaseBio Pharmaceuticals, Inc.
CI
Motion for Asset Sale Approved for PhaseBio Pharmaceuticals, Inc.
CI
Motion for De Minimis Assets Sale Approved for PhaseBio Pharmaceuticals, Inc.
CI
Notice of Selection of Auction and Asset Purchase Agreement Filed for Filed by PhaseBio Pharmaceuticals, Inc.
CI
Chiesi Farmaceutici S.p.A. cancelled the acquisition of all of the assets of PhaseBio Pharmaceuticals, Inc. primarily related to bentracimab.
CI
Notice of Rescheduled Auction Filed by PhaseBio Pharmaceuticals, Inc.
CI
Motion for Asset Sale Approved for PhaseBio Pharmaceuticals, Inc.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PHAS.Q Stock
  4. News PhaseBio Pharmaceuticals, Inc.